VERAVera Therapeutics, Inc.

Healthcare
$29.87+17% 1Y

The financials

Vera Therapeutics, Inc. by the numbers

The next results filing is expected around Nov 4, 2026, the same week as a year ago.

Vera Therapeutics, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$112M−$80Mn/a
Net income−$109M−$77Mn/a
Diluted EPS−$1.52−$1.20n/a
On our screens:Most shorted stocks

Biotechnology

Ranks #91 of 196 by RyuScore

Compare peers
RARE+1.4%
Ultragenyx Pharmaceutical Inc.
TARS+1.2%
Tarsus Pharmaceuticals, Inc.
IRON+2.2%
Disc Medicine, Inc.
KLRA+16%
Kailera Therapeutics, Inc.
CLDX+2.1%
Celldex Therapeutics, Inc.
ALMS+2.7%
Alumis Inc.